Obesity and prostate cancer screening in the USA.

Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Public Health (Impact Factor: 1.48). 08/2005; 119(8):694-8. DOI: 10.1016/j.puhe.2004.09.002
Source: PubMed

ABSTRACT To estimate the association between body mass index (BMI: kg/m2) and prostate-specific antigen (PSA) cancer screening in a nationally representative sample of US men aged 50 years and older using data from the 2001 Behavioral Risk Factor Surveillance Survey.
Men aged 50 years or older classified by BMI as healthy weight range (18.5-24.9), overweight (25-29.9), obese class I (30-34.9), obese class II (35-39.9), and obese class III (> or =40).
Interval since most recent screening for PSA.
Adjusting for age, race, smoking, education, employment, income and health insurance status, we found that, compared with men in the healthy weight range, men in the overweight [odds ratio (OR)=1.13; 95% confidence interval (95% CI)=1.04-1.35], obese class I (OR=1.26; 95% CI=1.06-1.36) and obese class II (OR=1.14, 95% CI=1.02-1.26) categories were significantly more likely to have obtained a PSA test within the previous year. A similar pattern was observed when we examined other screening intervals (e.g. within past 2 years, within past 3 years, etc.).
Among men aged 50 years and older, overweight and obesity is associated with obtaining a PSA test.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Promotion of prostate health remains an essential element of the men's health agenda. Prostatic disease contributes to the rate of morbidity and mortality of men, affecting their quality of life. More than 35 million men have experienced prostatic disease. Each year approximately 200,000 US men will be diagnosed with prostate cancer1 and 30,000 men will die of it.2 In addition to prostate cancer, prostatic disease consists of prostatitis (bacterial, nonbacterial), prostatodynia, and benign prostatic hyperplasia. Prostate cancer remains the predominant condition affecting prostate health.
    The Journal for Nurse Practitioners 09/2005; 1(2):70–71. DOI:10.1016/j.nurpra.2005.08.013
  • [Show abstract] [Hide abstract]
    ABSTRACT: Obesity has reached epidemic proportions and is recognized as a major cause of cancer worldwide (World Health Organization 2000, 2011). Obesity can be defined as an excess of body adiposity, which is evaluated according to the body weight. The body mass index (BMI) correlates weight and height (BMI = weight in kilograms divided by the square of the height in meters [kg/m2 ]), and since 1980, BMI has been considered the standard measure for evaluating whether a person is obese. In general, an individual with a BMI between 25 and 30 is classified as overweight or pre-obese, while an individual with a BMI over 30 is classified as obese; different intervals are established according to the mortality risk (Table 2.1) (Caballero 2007; World Health Organization 2000). Although data from the United States indicate that the incidence of obesity is increasing slowly or leveling off when compared to the past decade (Flegal et al. 2010, 2012), more than 1 billion people worldwide are overweight or obese (Deitel 2003). It has been estimated that 14% and 20% of all cancer deaths in men and women, respectively, can be attributed to excess body weight (Calle et al. 2003, 2004; Wolin et al. 2010). Obesity is associated with some types of cancer (Simard et al. 2012), such as colon, breast (postmenopausal), endometrial, kidney (renal cell), esophageal (adenocarcinoma), pancreatic, colorectal, and, potentially, gall bladder carcinoma (Wiseman 2008; Vainio et al. 2002). In addition...
    Inflammation, Oxidative Stress, and Cancer: Dietary Approaches for Cancer Prevention, Edited by Ah-Ng Tony Kong, 08/2013: chapter 2; CRC Press., ISBN: 9781466503700
  • Source